Yaku K - Search Results

1

Neuronal SIRT1 regulates macronutrient-based diet selection through FGF21 and oxytocin signalling in mice.

Matsui S, Sasaki T, Kohno D, Yaku K, Inutsuka A, Yokota-Hashimoto H, Kikuchi O, Suga T, Kobayashi M, Yamanaka A, Harada A, Nakagawa T, Onaka T, Kitamura T. Matsui S, et al. Among authors: yaku k. Nat Commun. 2018 Nov 2;9(1):4604. doi: 10.1038/s41467-018-07033-z. Nat Commun. 2018. PMID: 30389922 Free PMC article.

2

Novel role of serine racemase in anti-apoptosis and metabolism.

Talukdar G, Inoue R, Yoshida T, Ishimoto T, Yaku K, Nakagawa T, Mori H. Talukdar G, et al. Among authors: yaku k. Biochim Biophys Acta Gen Subj. 2017 Jan;1861(1 Pt A):3378-3387. doi: 10.1016/j.bbagen.2016.08.020. Epub 2016 Aug 30. Biochim Biophys Acta Gen Subj. 2017. PMID: 27585868

3

Simultaneous measurement of NAD metabolome in aged mice tissue using liquid chromatography tandem-mass spectrometry.

Yaku K, Okabe K, Nakagawa T. Yaku K, et al. Biomed Chromatogr. 2018 Jun;32(6):e4205. doi: 10.1002/bmc.4205. Epub 2018 Mar 25. Biomed Chromatogr. 2018. PMID: 29424941

4

NAD metabolism: Implications in aging and longevity.

Yaku K, Okabe K, Nakagawa T. Yaku K, et al. Ageing Res Rev. 2018 Nov;47:1-17. doi: 10.1016/j.arr.2018.05.006. Epub 2018 Jun 5. Ageing Res Rev. 2018. PMID: 29883761 Review.

5

Overexpression of Nmnat3 efficiently increases NAD and NGD levels and ameliorates age-associated insulin resistance.

Gulshan M, Yaku K, Okabe K, Mahmood A, Sasaki T, Yamamoto M, Hikosaka K, Usui I, Kitamura T, Tobe K, Nakagawa T. Gulshan M, et al. Among authors: yaku k. Aging Cell. 2018 Aug;17(4):e12798. doi: 10.1111/acel.12798. Epub 2018 Jun 14. Aging Cell. 2018. PMID: 29901258 Free PMC article.

6

Deletion of PHGDH in adipocytes improves glucose intolerance in diet-induced obese mice.

Okabe K, Usui I, Yaku K, Hirabayashi Y, Tobe K, Nakagawa T. Okabe K, et al. Among authors: yaku k. Biochem Biophys Res Commun. 2018 Sep 26;504(1):309-314. doi: 10.1016/j.bbrc.2018.08.180. Epub 2018 Sep 1. Biochem Biophys Res Commun. 2018. PMID: 30180949

7

NAD Metabolism in Cancer Therapeutics.

Yaku K, Okabe K, Hikosaka K, Nakagawa T. Yaku K, et al. Front Oncol. 2018 Dec 12;8:622. doi: 10.3389/fonc.2018.00622. eCollection 2018. Front Oncol. 2018. PMID: 30631755 Free PMC article. Review.

8

Implications of altered NAD metabolism in metabolic disorders.

Okabe K, Yaku K, Tobe K, Nakagawa T. Okabe K, et al. Among authors: yaku k. J Biomed Sci. 2019 May 11;26(1):34. doi: 10.1186/s12929-019-0527-8. J Biomed Sci. 2019. PMID: 31078136 Free PMC article. Review.

9

Implications of NAD metabolism in pathophysiology and therapeutics for neurodegenerative diseases.

Hikosaka K, Yaku K, Okabe K, Nakagawa T. Hikosaka K, et al. Among authors: yaku k. Nutr Neurosci. 2021 May;24(5):371-383. doi: 10.1080/1028415X.2019.1637504. Epub 2019 Jul 7. Nutr Neurosci. 2021. PMID: 31280708 Review.

10

Metabolism and biochemical properties of nicotinamide adenine dinucleotide (NAD) analogs, nicotinamide guanine dinucleotide (NGD) and nicotinamide hypoxanthine dinucleotide (NHD).

Yaku K, Okabe K, Gulshan M, Takatsu K, Okamoto H, Nakagawa T. Yaku K, et al. Sci Rep. 2019 Sep 11;9(1):13102. doi: 10.1038/s41598-019-49547-6. Sci Rep. 2019. PMID: 31511627 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters